Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled
its third quarter 2015 financial results conference call and webcast for
10:00 a.m. ET on Tuesday, November 3, 2015.
The schedule for the press release and conference call/webcast is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
• Q3 2015 Press Release:
|
|
|
November 3, 2015 at 7:00 a.m. ET
|
|
|
|
|
• Q3 2015 Conference Call:
|
|
|
November 3, 2015 at 10:00 a.m. ET
|
|
|
|
|
• Domestic Dial-In Number:
|
|
|
877-407-9221
|
|
|
|
|
• International Dial-In Number:
|
|
|
201-689-8597
|
|
|
|
|
• Conference ID Number:
|
|
|
13622010
|
|
|
|
|
|
|
|
|
If you are unable to participate, a replay of the conference call will
be available for thirty days. The replay dial-in number for the U.S. is
877-660-6853 and the dial-in number for international callers is
201-612-7415. To access the replay you will need the conference ID
number 13622010.
The live webcast with slides can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts and will be available for
replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary therapeutics, primarily for oncology. For additional
information on Incyte, please visit the Company's web site at www.incyte.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151013005021/en/
Copyright Business Wire 2015